ZA200808236B - Improved dosing and scheduling of oligomers - Google Patents

Improved dosing and scheduling of oligomers

Info

Publication number
ZA200808236B
ZA200808236B ZA200808236A ZA200808236A ZA200808236B ZA 200808236 B ZA200808236 B ZA 200808236B ZA 200808236 A ZA200808236 A ZA 200808236A ZA 200808236 A ZA200808236 A ZA 200808236A ZA 200808236 B ZA200808236 B ZA 200808236B
Authority
ZA
South Africa
Prior art keywords
oligomers
scheduling
improved dosing
dosing
improved
Prior art date
Application number
ZA200808236A
Other languages
English (en)
Inventor
Bob D Brown
Original Assignee
Genta Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genta Inc filed Critical Genta Inc
Publication of ZA200808236B publication Critical patent/ZA200808236B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Transplantation (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA200808236A 2006-03-31 2007-03-31 Improved dosing and scheduling of oligomers ZA200808236B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US78784606P 2006-03-31 2006-03-31

Publications (1)

Publication Number Publication Date
ZA200808236B true ZA200808236B (en) 2010-03-31

Family

ID=38625496

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200808236A ZA200808236B (en) 2006-03-31 2007-03-31 Improved dosing and scheduling of oligomers

Country Status (14)

Country Link
US (1) US20070270371A1 (ko)
EP (1) EP2007203A2 (ko)
JP (1) JP2009538272A (ko)
KR (1) KR20080108587A (ko)
CN (1) CN101394744A (ko)
AU (1) AU2007240972A1 (ko)
BR (1) BRPI0709651A2 (ko)
CA (1) CA2644584A1 (ko)
CR (1) CR10394A (ko)
EA (1) EA200870395A1 (ko)
IL (1) IL193816A0 (ko)
MX (1) MX2008012345A (ko)
WO (1) WO2007123779A2 (ko)
ZA (1) ZA200808236B (ko)

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5734033A (en) * 1988-12-22 1998-03-31 The Trustees Of The University Of Pennsylvania Antisense oligonucleotides inhibiting human bcl-2 gene expression
US5831066A (en) * 1988-12-22 1998-11-03 The Trustees Of The University Of Pennsylvania Regulation of bcl-2 gene expression
US5994320A (en) * 1995-02-06 1999-11-30 Regents Of The University Of Minnesota Antisense oligonucleotides and methods for treating central nervous system tumors
US6214986B1 (en) * 1998-10-07 2001-04-10 Isis Pharmaceuticals, Inc. Antisense modulation of bcl-x expression
US20040147473A1 (en) * 2000-11-10 2004-07-29 Warrell Raymond P. Methods of treatment of a bcl-2 disorder using bcl-2 antisense oligomers
US7855183B2 (en) * 2000-11-10 2010-12-21 Genta Incorporated Methods of treatment of a bcl-2 disorder using bcl-2 antisense oligomers
EP1351678A2 (en) * 2001-01-02 2003-10-15 Elizabeth Shanahan-Prendergast Treatment for inhibiting neoplastic lesions using incensole and/or furanogermacrens
KR20040004629A (ko) * 2001-05-17 2004-01-13 에이브이아이 바이오파마 인코포레이티드 ｃ-ｍｙｃ 안티센스 올리고머를 사용한 암치료를 위한조합 접근법
AU2004209579B2 (en) * 2003-02-10 2010-03-04 Lorus Therapeutics Inc. Antisense oligonucleotides directed to ribonucleotide reductase R2 and uses thereof in the treatment of cancer

Also Published As

Publication number Publication date
EP2007203A2 (en) 2008-12-31
CR10394A (es) 2009-01-30
BRPI0709651A2 (pt) 2011-07-19
CN101394744A (zh) 2009-03-25
KR20080108587A (ko) 2008-12-15
WO2007123779A3 (en) 2008-11-06
CA2644584A1 (en) 2007-11-01
JP2009538272A (ja) 2009-11-05
EA200870395A1 (ru) 2009-04-28
US20070270371A1 (en) 2007-11-22
MX2008012345A (es) 2008-11-12
AU2007240972A1 (en) 2007-11-01
IL193816A0 (en) 2009-08-03
WO2007123779A2 (en) 2007-11-01

Similar Documents

Publication Publication Date Title
HUS2100008I1 (hu) Halauxifen-metil és floraszulam kombinációja
IL264138A (en) Immunoglobulin variants and their uses
PL2247553T3 (pl) Stabilizowane ceramiczne struktury typu plastra miodu o niskiej zawartości mikropęknięć i ich sposoby
PT2371958E (pt) Novos sirna e métodos para a sua utilização
HK1152940A1 (en) Novel substituted pyridin-2-ones and pyridazin-3-ones -2--3-
IL201019A0 (en) Asparaginase enzyme variants and uses thereof
EP2316091A4 (en) PROGRAMMING OPERATIONS IN PROTECTED MODE
EP2314544A4 (en) BETA-ZEOLITE WITH HIGH RESISTANCE TO HEAT AND SCR CATALYST THEREFOR
EP2437052A4 (en) BIOSENSOR AND USE THEREOF
IL208438A0 (en) Compositions for enhancing the antibacterial activity of myeloperoxidase and methods of use thereof
EP2069239A4 (en) SOL-GEL PRECURSORS AND CORRESPONDING PRODUCTS
EP2246428A4 (en) MODIFIED TRNA WITH NON-NATURAL NUCLEOTIDE AND USE THEREOF
EP2099597A4 (en) RECEIVER BLOCK MOLD AND USE THEREOF
EP2493932A4 (en) CATALYTIC COMPOUNDS AND THEIR USE
EP2493933A4 (en) CATALYTIC COMPOUNDS AND THEIR USE
EP2388320A4 (en) ANTI-HS6ST2 ANTIBODIES AND USE THEREOF
EP2442957A4 (en) IMPROVED INJECTION AND / OR ASSAY SYSTEM
EP2246430A4 (en) ANTI-ADAM-15 ANTIBODIES AND THEIR USE
EP2018782A4 (en) LOGIC OF SCHEDULING
PT2154144E (pt) Oligonucleotídeos e utilização dos mesmos
EP1999313A4 (en) TERMINATION WITH TIME AND TEMPERATURE SUPPLEMENT
EP2123615A4 (en) CERAMIC ELEMENT AND CORROSION RESISTANT ELEMENT
EP2243773A4 (en) PLATINUM COMPLEX CONNECTION AND ITS USE
IL193816A0 (en) Improved dosing and scheduling of oligomers
ZA200808284B (en) Personal care article